A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ramucirumab
Related studies linked through entity extraction aliases.
Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1
International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2801653 in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2157299 in Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Second Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ramucirumab or Icrucumab in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE3